Antigen therapy of experimental autoimmune encephalomyelitis selectively induces apoptosis of pathogenic T cells

Journal of Neuroimmunology

Volumn 183, Issue 1-2, 2007, Pages 146-150

  Tischner, Denise ^a   Weishaupt, Andreas ^a   van den Brandt, Jens ^a   Ip, Chi Wang ^a   Kerkau, Thomas ^a   Gold, Ralf ^b   Reichardt, Holger M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Antigen therapy; Experimental autoimmune encephalomyelitis; Multiple sclerosis; T cell apoptosis; Transgenic rat

Indexed keywords

MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CELL LINE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SPINAL CORD; SPLEEN; T LYMPHOCYTE; TARGET CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; APOPTOSIS; CASPASE 3; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; SPINAL CORD; SPLEEN; T-LYMPHOCYTES;

EID: 33846847853     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.11.031     Document Type: Article

References (18)

1. Arnon R., and Sela M. Immunomodulation by the copolymer glatiramer acetate. J. Mol. Recognit. 16 (2003) 412-421
2. Ben-Nun A., Wekerle H., and Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11 (1981) 195-199
3. Chan A., Gold R., Giegerich G., Herrmann T., Jung S., Toyka K.V., and Hartung H.P. Usage of Vbeta3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat. J. Neurosci. Res. 58 (1999) 214-225
4. Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., Cannella B., Raine C.S., Goverman J., and Lenardo M.J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263 (1994) 1139-1143
5. Flügel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., Ellwart J.W., Willem M., Lassmann H., and Wekerle H. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14 (2001) 547-560
6. Fontoura P., Steinman L., and Miller A. Emerging therapeutic targets in multiple sclerosis. Curr. Opin. Neurol. 19 (2006) 260-266
7. Gold R., Hartung H.P., and Lassmann H. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 20 (1997) 399-404
8. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
9. Ishigami T., White C.A., and Pender M.P. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Eur. J. Immunol. 28 (1998) 1626-1635
10. Murray T.J. Diagnosis and treatment of multiple sclerosis. BMJ 332 (2006) 525-527
11. Schmidt J., Metselaar J.M., Wauben M.H., Toyka K.V., Storm G., and Gold R. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 126 (2003) 1895-1904
12. Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol. Rev. 184 (2001) 129-135
13. Tischner D., Weishaupt A., Brandt J.V., Müller N., Beyersdorf N., Ip C.W., Toyka K.V., Hünig T., Gold R., Kerkau T., and Reichardt H.M. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain 129 (2006) 2635-2647
14. van den Brandt J., Wang D., Kwon S.H., Heinkelein M., and Reichardt H.M. Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39 (2004) 94-99
15. van den Brandt J., Kwon S.H., Hünig T., McPherson K.G., and Reichardt H.M. Sustained pre-TCR expression in Notch1IC-transgenic rats impairs T cell maturation and selection. J. Immunol. 174 (2005) 7845-7852
16. Weishaupt A., Gold R., Gaupp S., Giegerich G., Hartung H.P., and Toyka K.V. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1338-1343
17. Weishaupt A., Jander S., Brück W., Kuhlmann T., Stienekemeier M., Hartung T., Toyka K.V., Stoll G., and Gold R. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J. Immunol. 165 (2000) 7157-7163
18. Weishaupt A., Brück W., Hartung T., Toyka K.V., and Gold R. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha. Neurosci. Lett. 306 (2001) 77-80